GMAB

Genmab A/S

Price

$28.80

return (12m)

21.88%

p/e

21.95

p/bv

3.17

DIVIDEND YIELD

0.00%

GMAB price

Genmab

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment GMAB

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

11.35%

3 months

7.18%

1 year

21.88%

2 years

3.30%

5 years

-34.66%

10 years

62.95%

Fundamentals GMAB

Valuation

P/E

21.95

Sector 10.60

Industry 47.87

P/BV

3.17

Sector 1.65

Industry 12.62

P/Revenue (PSR)

4.62

Sector 0.99

Industry 3.59

EV/EBITDA

99.69

Sector 23.42

Industry 48.82

EV/EBIT

115.23

Sector 26.14

Industry 64.95

P/EBITDA

14.01

Sector 5.34

Industry 37.35

P/EBIT

14.99

Sector 6.99

Industry 58.58

P/Total Assets

1.46

Sector 0.80

Industry 2.91

P/Ativo Circ. Liq.

-4.37

Sector -5.72

Industry -10.74

P/Cap.Giro

12.92

Sector -3.47

Industry 69.35

EPS

1.30

Sector 0.79

Industry 37.87

BVPS

9.00

Sector 10.37

Industry 143.62

Efficiency

Gross Margin

93.31%

Sector 38.90%

Industry 50.60%

EBITDA Margin

24.00%

Sector 8.04%

Industry 32.82%

EBIT Margin

20.76%

Sector 3.46%

Industry 22.39%

Operating Margin

32.99%

Sector 5.61%

Industry 11.50%

Net Profit Margins

21.05%

Sector 1.82%

Industry 12.22%

Giro Ativos

0.07

Sector 0.21

Industry 0.20

Profitability

ROE

14.45%

Sector 4.04%

Industry 26.37%

ROA

6.63%

Sector 1.00%

Industry 9.91%

ROIC

6.31%

Sector -8.01%

Industry 11.23%

Dividends

Dividend yield

0.00%

Sector 0.38%

Industry 0.91%

Payout

0.00%

Sector 9.68%

Industry 16.71%

Debt

Current Ratio

2.18

Sector 1.12

Industry 1.28

Dívida Líquida/EBITDA

15.87

Sector 1.68

Industry -0.40

Dívida Líquida/EBIT

18.34

Sector 1.11

Industry -0.59

Dívida Líquida/Patrimônio

0.60

Sector -0.10

Industry -0.05

Dívida Bruta/Patrimônio

0.87

Sector 0.24

Industry 0.27

Equity/Assets

0.46

Sector 0.31

Industry 0.59

Liabilities/Assets

0.54

Sector 0.60

Industry 0.84

Growth

5Y Revenue CAGR

24.74%

Sector -

Industry -

5Y Earnings CAGR

12.62%

Sector -

Industry -

FAIR VALUE OF Genmab ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$28.80

Fair Value

$16.22

Upside Return potential.

-43.66%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals GMAB

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
GMAB	21.95	3.17	14.45%	0.00%	$18.02 B	21.05%
V	29.10	18.14	62.35%	0.73%	$647.05 B	51.68%
PAYX	22.93	10.81	47.12%	3.93%	$40.36 B	27.03%
MCO	36.08	28.64	79.38%	0.77%	$90.03 B	31.69%
BKNG	23.11	-16.30	-70.54%	0.89%	$142.19 B	22.23%
ROL	41.11	15.75	38.31%	1.57%	$21.76 B	13.77%
WM	34.63	9.66	27.88%	1.47%	$96.77 B	10.99%
CPRT	16.50	2.92	17.67%	0.00%	$25.63 B	33.48%
GFI	6.00	3.33	55.49%	5.70%	$28.89 B	34.49%
RHI	31.57	3.32	10.51%	5.78%	$4.09 B	2.43%
FLT	19.65	5.88	29.91%	0.00%	$19.29 B	26.13%
TTEK	18.49	4.37	23.62%	0.85%	$8.14 B	8.58%
WMG	32.47	15.10	46.50%	2.70%	$14.68 B	6.34%
EFX	30.30	4.52	14.92%	1.20%	$21.17 B	11.12%
EXLS	17.29	5.59	32.30%	0.00%	$4.35 B	11.66%
PKOH	22.76	1.41	6.19%	1.30%	$537.18 M	1.46%
VSEC	108.58	2.03	1.87%	0.20%	$5.40 B	4.21%
HCSG	25.90	3.42	13.21%	0.00%	$1.76 B	3.66%
TIF	34.21	5.03	14.71%	0.00%	$15.95 B	10.91%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

GMAB Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Genmab

Genmab A/S

Average Investor10 user rating

4.0 (9 people)

United States

28 years

Founded: 1998

2019

Time since IPO - 7 years

781

Employees

Genmab A/S (United States) is listed on the Nasdaq and has a market capitalization of $18.02 billion, with shareholders equity totaling $5.68 billion.

The company employs approximately 781 people and operates in the Services sector, within the Commercial Services industry.

Over the past 12 months, Genmab A/S reported $3.90 billion in revenue, generating net income of $821.00 million.

Key financial metrics include a P/E ratio of 21.95, a price-to-book (P/B) ratio of 3.17, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker GMAB.

Market cap

$18.02 billion

Net worth

$5.68 billion

$5,682,000,000.00

Assets

$12.38 billion

$12,376,000,000.00

Total Shares Outstanding

631.00 million

631,000,000

Average Daily Trading Volume

$2.11 million

$2,113,472.00

Sector

Services

Industry

Commercial Services

GMAB

GMAB revenue and profits

Financial Results GMAB

DRAG THE FRAME TO SEE MORE DATA

GMAB cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

AMZN - Amazon

$233.46 0,29% (12M)

P/E

29.33

0.00%

ROE

20.55%

P/BV

6.03

WMT - Walmart

$109.07 13,33% (12M)

P/E

40.00

0.85%

ROE

22.52%

P/BV

9.01

COST - Costco Wholesale

$932.41 0,39% (12M)

P/E

47.10

0.57%

ROE

26.38%

P/BV

12.42

KR - Kroger

$56.48 --16,27% (12M)

P/E

34.66

2.38%

ROE

16.12%

P/BV

5.59

JD - JD.com

$30.39 --5,28% (12M)

P/E

17.85

3.85%

ROE

4.80%

P/BV

0.86

HD - Home Depot

$331.05 --9,45% (12M)

P/E

24.42

2.69%

ROE

100.99%

P/BV

24.66

WBA - Walgreens Boots Alliance

$- -0,00% (12M)

P/E

-1.76

4.17%

ROE

-80.35%

P/BV

1.42

BABA - Alibaba

$113.14 --5,74% (12M)

P/E

18.36

0.91%

ROE

8.96%

P/BV

1.64